tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX

Compare Insight Molecular Diagnostics (IMDX) vs. Competitors

Compare
431 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Insight Molecular Diagnostics
$6.52
$186.89M
-2.30
224.38%
2 Buy
1 Hold
0 Sell
Moderate Buy
Atossa Therapeutics
$0.56
$72.98M
-2.41
-34.68%
4 Buy
0 Hold
0 Sell
Strong Buy
MacroGenics
$1.83
$115.76M
-1.52
-39.20%
1 Buy
2 Hold
0 Sell
Moderate Buy
Elutia
$0.64
$44.84M
-1.14
-66.13%
2 Buy
0 Hold
0 Sell
Moderate Buy
Surrozen
$21.54
$184.67M
-0.99
78.50%
3 Buy
0 Hold
0 Sell
Strong Buy
Telomir Pharmaceuticals, Inc.
$1.35
$39.19M
-3.05
-74.78%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMDX
Insight Molecular Diagnostics
6.52
4.39
206.10%
ATOS
Atossa Therapeutics
0.57
-0.28
-33.29%
MGNX
MacroGenics
1.83
-1.02
-35.79%
ELUT
Elutia
1.05
-1.71
-61.96%
SRZN
Surrozen
21.55
10.64
97.48%
TELO
Telomir Pharmaceuticals, Inc.
1.14
-3.03
-72.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts